DTC Comparative Drug Campaigns To Be Addressed At FDA Public Meeting
Executive Summary
Standards for comparative drug claims in direct-to-consumer ads will be one topic for discussion during a Sept. 22-23 FDA public meeting on consumer-directed promotion of prescription drugs
You may also be interested in...
Print Ads Should Use Limited “Brief Summary” Like TV Spots, FTC Tells FDA
The Federal Trade Commission is encouraging FDA to ease its requirements for direct-to-consumer print advertisements and allow them to include a more limited "brief summary" like TV ads do
Print Ads Should Use Limited “Brief Summary” Like TV Spots, FTC Tells FDA
The Federal Trade Commission is encouraging FDA to ease its requirements for direct-to-consumer print advertisements and allow them to include a more limited "brief summary" like TV ads do
DTC Effect On Patient Benefit, Compliance Needs More Study – FDA’s Temple
The effect of direct-to-consumer advertising on patient behavior needs to be further studied, FDA Center for Drug Evaluation & Research Office of Medical Policy Director Robert Temple, MD, suggested